Overactivation of the IGF signalling pathway in osteosarcoma

ABSTRACT: Tumour samples (low coverage WGS) from 35 patients with osteosarcoma were included. All samples were re-evaluated by an experienced bone pathologist who conï¬Ârmed the diagnosis and a tumour content >50% per sample. All tumours represented conventional high-grade osteosarcomas.

PROVIDER: EGAS00001004767 | EGA |

REPOSITORIES: EGA